Corporate Balance Sheets Show Strength

competitors have borrowed to raise extra cash at a time of record-low interest rates. In the past year, King Pharmaceuticals (KG) cut 52% of its liabilities, a total of $1 billion. Biotechnology company Amgen (AMGN) added $1.4 billion, or 9.1%, to its...